Envision Healthcare and AMSURG Shareholders Approve Merger

November 28, 2016 04:05 PM Eastern Daylight Time

GREENWOOD VILLAGE, Colo. & NASHVILLE, Tenn.--(EON: Enhanced Online News)--Envision Healthcare Holdings, Inc. (NYSE: EVHC, “Envision”) and AMSURG
Corp. (NASDAQ: AMSG, “AMSURG”) announced that the shareholders of both
companies voted to approve the previously announced merger of the two
companies at separate special meetings held today.

Holders of over 82 percent of shares of Envision’s common stock
outstanding and entitled to vote, or over 96 percent of votes cast,
voted to approve the merger. Holders of 88 percent of shares of AMSURG’s
common stock outstanding and entitled to vote, or over 99 percent of
votes cast, voted to approve the merger. Envision and AMSURG will each
file a Form 8-K later today disclosing the full voting results.

The combination of Envision and AMSURG brings together two leading,
complementary healthcare companies to form one of the nation’s largest
healthcare provider organizations, well positioned to help shape the
future of healthcare delivery. The companies expect to complete the
merger on December 1, 2016.

No Offer / Additional Information and Where to Find It

This communication is for informational purposes only and does not
constitute an offer to sell or the solicitation of an offer to buy any
securities with respect to the proposed business combination between
Envision and AMSURG or otherwise, nor shall there be any sale, issuance
or transfer of securities in any jurisdiction in contravention of
applicable law. No offer of securities shall be made except by means of
a prospectus meeting the requirements of Section 10 of the Securities
Act of 1933, as amended. The proposed business combination between
Envision and AMSURG was approved by their respective shareholders on
November 28, 2016. On August 4, 2016, AMSURG caused its newly formed,
wholly owned subsidiary, New Amethyst Corp. (“New Amethyst”), to file
with the Securities and Exchange Commission (the “SEC”) a Registration
Statement on Form S-4 (File No. 333-212885) that constitutes a
prospectus of New Amethyst and a joint proxy statement of Envision and
AMSURG. The SEC declared the Form S-4, as subsequently amended,
effective on October 19, 2016. Envision and AMSURG have caused the
definitive joint proxy statement/final prospectus to be mailed to their
respective shareholders, as required by applicable law. This
communication is not a substitute for the definitive joint proxy
statement/final prospectus, or any other document that may be filed with
the SEC in connection with the proposed business combination. Investors
and shareholders are urged to read carefully and in their entirety the
definitive joint proxy statement/final prospectus delivered to
shareholders, and any other relevant documents that are filed with the
SEC when they become available, because they contain important
information about the proposed business combination and related matters.
Investors and shareholders may obtain free copies of the definitive
joint proxy statement/final prospectus and other documents containing
important information about Envision, AMSURG and New Amethyst, once such
documents are filed with the SEC, through the website maintained by the
SEC at www.sec.gov.
Envision and AMSURG make available free of charge at www.evhc.net
and www.amsurg.com,
respectively (in the “Investors” section), copies of materials they file
with, or furnish to, the SEC.

Forward-Looking Statements

Certain statements and information in this communication may be deemed
to be “forward-looking statements” within the meaning of the Federal
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may include, but are not limited to, statements relating to
Envision’s and AMSURG’s objectives, plans and strategies, and all
statements (other than statements of historical facts) that address
activities, events or developments that Envision and AMSURG intend,
expect, project, believe or anticipate will or may occur in the future.
These statements are often characterized by terminology such as
“believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,”
“will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and
similar expressions, and are based on assumptions and assessments made
by Envision’s and AMSURG’s management in light of their experience and
their perception of historical trends, current conditions, expected
future developments, and other factors they believe to be appropriate.
Any forward-looking statements in this communication are made as of the
date hereof, and Envision and AMSURG undertake no duty to update or
revise any such statements, whether as a result of new information,
future events or otherwise. Forward-looking statements are not
guarantees of future performance. Whether actual results will conform to
expectations and predictions is subject to known and unknown risks and
uncertainties, including: (i) risks and uncertainties discussed in the
reports that Envision and AMSURG have filed with the SEC; (ii) general
economic, market, or business conditions; (iii) the impact of
legislative or regulatory changes, such as changes to the Patient
Protection and Affordable Care Act, as amended by the Health Care and
Education Reconciliation Act of 2010; (iv) changes in governmental
reimbursement programs; (v) decreases in revenue and profit margin under
fee-for-service contracts due to changes in volume, payor mix and
reimbursement rates; (vi) the loss of existing contracts; (vii) risks
associated with the ability to consummate the business combination
between Envision and AMSURG and the timing of the closing of the
business combination; (viii) the ability to successfully integrate
Envision’s and AMSURG’s operations and employees; (ix) the ability to
realize anticipated benefits and synergies of the business combination;
(x) the potential impact of announcement of the business combination or
consummation of the transaction on relationships, including with
employees, customers and competitors; and (xi) other circumstances
beyond Envision’s and AMSURG’s control. Refer to the section entitled
“Risk Factors” in Envision’s and AMSURG’s recent filings with the SEC,
including their annual and quarterly reports for a discussion of
important factors that could cause actual results, developments and
business decisions to differ materially from forward-looking statements.